• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 severity, miR-21 targets, and common human genetic variation. Letter regarding the article 'Circulating cardiovascular microRNAs in critically ill COVID-19 patients'.

作者信息

Dingsdag Simon A, Clay Oliver K, Quintero Gustavo A

机构信息

Translational Microbiology and Emerging Diseases (MICROS), Universidad del Rosario, Bogotá, Colombia.

出版信息

Eur J Heart Fail. 2021 Nov;23(11):1986-1987. doi: 10.1002/ejhf.2317. Epub 2021 Aug 9.

DOI:10.1002/ejhf.2317
PMID:34318976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8427028/
Abstract
摘要

相似文献

1
COVID-19 severity, miR-21 targets, and common human genetic variation. Letter regarding the article 'Circulating cardiovascular microRNAs in critically ill COVID-19 patients'.新冠病毒疾病严重程度、miR-21靶点及常见人类基因变异。关于文章《危重症新冠病毒疾病患者循环心血管微小RNA》的信函。
Eur J Heart Fail. 2021 Nov;23(11):1986-1987. doi: 10.1002/ejhf.2317. Epub 2021 Aug 9.
2
Circulating cardiovascular microRNAs in critically ill COVID-19 patients.危重症 COVID-19 患者循环心血管 microRNAs。
Eur J Heart Fail. 2021 Mar;23(3):468-475. doi: 10.1002/ejhf.2096. Epub 2021 Mar 5.
3
Reply to 'COVID-19 severity, miR-21 targets, and common human genetic variation'.对《COVID-19严重程度、miR-21靶点及常见人类基因变异》的回复
Eur J Heart Fail. 2021 Nov;23(11):1987-1988. doi: 10.1002/ejhf.2322. Epub 2021 Aug 10.
4
A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.一项关于无慢性肾脏病的重症 COVID-19 患者急性肾损伤的调查。
Ann Palliat Med. 2021 Jun;10(6):6198-6207. doi: 10.21037/apm-20-2170. Epub 2021 May 17.
5
Critically Ill . Non-Critically Ill Patients With COVID-19 Pneumonia: Clinical Features, Laboratory Findings, and Prediction.危重症/非危重症 COVID-19 肺炎患者：临床特征、实验室检查结果和预测因素。
Front Cell Infect Microbiol. 2021 Jul 13;11:550456. doi: 10.3389/fcimb.2021.550456. eCollection 2021.
6
The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative.淋巴细胞计数在判断 COVID-19 严重程度和预测核酸检测结果转阴时间方面的价值。
Bosn J Basic Med Sci. 2021 Apr 1;21(2):235-241. doi: 10.17305/bjbms.2020.4868.
7
Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.高度敏感的血浆严重急性呼吸综合征冠状病毒 2 核酸定量分析揭示了其潜在的临床价值。
Clin Infect Dis. 2021 Nov 2;73(9):e2890-e2897. doi: 10.1093/cid/ciaa1196.
8
The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure.miR-320 家族在 COVID-19 诱导的严重呼吸衰竭患者中强烈下调。
Int J Mol Sci. 2021 Sep 26;22(19):10351. doi: 10.3390/ijms221910351.
9
Outcomes of Covid-19 organizing pneumonia in critically ill patients.危重症患者新冠病毒感染相关机化性肺炎的转归
J Infect. 2021 Oct;83(4):496-522. doi: 10.1016/j.jinf.2021.06.025. Epub 2021 Jul 1.
10
Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.两名危重症新冠肺炎患者肺移植前后的免疫反应及残余严重急性呼吸综合征冠状病毒2
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.006. Epub 2020 Nov 12.

引用本文的文献

1
Altered expression of serum lncRNA CASC2 and miRNA-21-5p in COVID-19 patients.COVID-19 患者血清长链非编码 RNA CASC2 和 miRNA-21-5p 的表达改变。
Hum Genomics. 2024 Feb 12;18(1):18. doi: 10.1186/s40246-024-00578-9.
2
Role of circulatory miRNA-21 and associated signaling pathways in the pathogenesis of pulmonary fibrosis among individuals recovered after COVID-19 infection.循环miRNA-21及其相关信号通路在新冠感染康复者肺纤维化发病机制中的作用
Hum Gene (Amst). 2022 Dec;34:201093. doi: 10.1016/j.humgen.2022.201093. Epub 2022 Jul 28.
3
Distinct Features of Vascular Diseases in COVID-19.新冠病毒病中血管疾病的独特特征
J Inflamm Res. 2023 Jul 6;16:2783-2800. doi: 10.2147/JIR.S417691. eCollection 2023.
4
miRNAs: The Key Regulator of COVID-19 Disease.微小RNA：新冠病毒疾病的关键调节因子
Int J Cell Biol. 2022 Oct 29;2022:1645366. doi: 10.1155/2022/1645366. eCollection 2022.
5
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review.SARS-CoV-2感染中的微小RNA与炎症免疫反应：一篇叙述性综述
Life (Basel). 2022 Feb 15;12(2):288. doi: 10.3390/life12020288.
6
miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19.miRNAs，从进化垃圾到 COVID-19 中的可能预后标志物和治疗靶点。
Viruses. 2021 Dec 27;14(1):41. doi: 10.3390/v14010041.
7
Association of cardiometabolic microRNAs with COVID-19 severity and mortality.心血管代谢 microRNAs 与 COVID-19 严重程度和死亡率的关联。
Cardiovasc Res. 2022 Jan 29;118(2):461-474. doi: 10.1093/cvr/cvab338.